BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anlon Healthcare Ltd IPO is open
Apply for the Anlon Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

523696

FORTISMLR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

FORTIS MALAR HOSPITALS LIMITED Share Price Update

As of the latest trading session, FORTIS MALAR HOSPITALS LIMITED share price is currently at ₹ 67.42, which is down by ₹ -0.59 from its previous closing. Today, the stock has fluctuated between ₹ 67.00 and ₹ 68.90. Over the past year, FORTIS MALAR HOSPITALS LIMITED has achieved a return of 10.06 %. In the last month alone, the return has been -0.17 %. Read More...

Investment Returns

Over 1 Month -0.17% Over 3 Months -11.92% Over 6 Months 15.54% Over 1 Year 10.06%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

FORTIS MALAR HOSPITALS LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    126.40

  • P/E Ratio (TTM)

    27.43

  • Beta

    0.72

  • Book Value / share

    15.97

  • Return on equity

    0.59%

  • EPS (TTM)

    2.48

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    4.18

info icon alternate text

FORTIS MALAR HOSPITALS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.30
Net Profit 4.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.23
EBITDA 4.31
Effective Tax Rate (%) 3.01
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit 0.36
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.19
EBITDA 0.40
Effective Tax Rate (%) 10.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.40
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.15
Effective Tax Rate (%) 93.33
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.46
Net Profit 0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.05
EBITDA 0.09
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.89
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 2.13
Net Profit 0.41
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.22
EBITDA 0.60
Effective Tax Rate (%) 30.50
Particulars MAR 2024 (Values in Cr)
Revenue 59.01
Operating Expense 73.86
Net Profit 47.28
Net Profit Margin (%) 80.12
Earnings Per Share (EPS) 25.23
EBITDA 65.61
Effective Tax Rate (%) 8.98
Particulars MAR 2023 (Values in Cr)
Revenue 85.95
Operating Expense 99.59
Net Profit -15.53
Net Profit Margin (%) -18.06
Earnings Per Share (EPS) -8.29
EBITDA 11.14
Effective Tax Rate (%) -119.49
Particulars MAR 2022 (Values in Cr)
Revenue 86.18
Operating Expense 101.82
Net Profit -8.31
Net Profit Margin (%) -9.64
Earnings Per Share (EPS) -4.43
EBITDA 10.77
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 69.24
Operating Expense 95.64
Net Profit -8.01
Net Profit Margin (%) -11.56
Earnings Per Share (EPS) -4.28
EBITDA 8.61
Effective Tax Rate (%) 30.07
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.11
ROE % 0.56
ROCE % 0.83
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.36
ROE % -9.12
ROCE % -3.24
Total Debt to Total Equity 0.27
EBITDA Margin 9.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.21
ROE % -21.45
ROCE % -0.75
Total Debt to Total Equity 0.69
EBITDA Margin 13.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.72
ROE % -9.79
ROCE % -1.19
Total Debt to Total Equity 0.65
EBITDA Margin 12.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.31
ROE % -15.90
ROCE % -7.05
Total Debt to Total Equity 0.66
EBITDA Margin 2.76
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.97
ROE % 0.59
ROCE % 0.86
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.22
ROE % -6.99
ROCE % -1.52
Total Debt to Total Equity 0.27
EBITDA Margin 13.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 33.03
ROE % -22.20
ROCE % -0.81
Total Debt to Total Equity 0.71
EBITDA Margin 12.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.57
ROE % -10.10
ROCE % -1.25
Total Debt to Total Equity 0.67
EBITDA Margin 12.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 46.18
ROE % -16.42
ROCE % -7.24
Total Debt to Total Equity 0.67
EBITDA Margin 2.54
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.79
Total Assets 36.83
Total Liabilities 36.83
Total Equity 30.20
Share Outstanding 18741759
Price to Book Ratio 4.60
Return on Assets (%) 1.06
Return on Capital (%) 1.3
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 108.22
Total Assets 115.87
Total Liabilities 115.87
Total Equity 109.46
Share Outstanding 18741759
Price to Book Ratio 0.80
Return on Assets (%) 39.11
Return on Capital (%) 41.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.43
Total Assets 137.99
Total Liabilities 137.99
Total Equity 64.17
Share Outstanding 18741759
Price to Book Ratio 1.44
Return on Assets (%) -11.21
Return on Capital (%) -24.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.55
Total Assets 160.91
Total Liabilities 160.91
Total Equity 80.13
Share Outstanding 18741759
Price to Book Ratio 1.39
Return on Assets (%) -5.14
Return on Capital (%) -10.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.56
Total Assets 169.09
Total Liabilities 169.09
Total Equity 88.74
Share Outstanding 18741759
Price to Book Ratio 1.20
Return on Assets (%) -4.65
Return on Capital (%) -8.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.70
Total Assets 36.57
Total Liabilities 36.57
Total Equity 29.96
Share Outstanding 18741759
Price to Book Ratio 4.60
Return on Assets (%) 1.12
Return on Capital (%) 1.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.10
Total Assets 115.38
Total Liabilities 115.38
Total Equity 109.20
Share Outstanding 18741759
Price to Book Ratio 0.80
Return on Assets (%) 40.97
Return on Capital (%) 43.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.30
Total Assets 135.69
Total Liabilities 135.69
Total Equity 61.95
Share Outstanding 18741759
Price to Book Ratio 1.44
Return on Assets (%) -11.44
Return on Capital (%) -25.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 10.48
Total Assets 158.67
Total Liabilities 158.67
Total Equity 77.97
Share Outstanding 18741759
Price to Book Ratio 1.39
Return on Assets (%) -5.23
Return on Capital (%) -10.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.60
Total Assets 166.98
Total Liabilities 166.98
Total Equity 86.61
Share Outstanding 18741759
Price to Book Ratio 1.20
Return on Assets (%) -4.79
Return on Capital (%) -9.25
Particulars MAR 2024 (Values in Cr)
Net Income 50.00
Cash from Operations -2.27
Cash from Investing 119.70
Cash from Financing -10.85
Net change in Cash 101.54
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income -7.00
Cash from Operations 5.52
Cash from Investing 0.49
Cash from Financing -12.65
Net change in Cash -6.54
Free Cash Flow 7.40
Particulars MAR 2022 (Values in Cr)
Net Income -8.26
Cash from Operations 7.56
Cash from Investing 8.23
Cash from Financing -10.10
Net change in Cash 4.97
Free Cash Flow 8.96
Particulars MAR 2021 (Values in Cr)
Net Income -11.31
Cash from Operations -12.95
Cash from Investing -27.51
Cash from Financing -7.24
Net change in Cash -35.62
Free Cash Flow -12.42
Particulars MAR 2020 (Values in Cr)
Net Income -11.93
Cash from Operations 3.86
Cash from Investing 49.88
Cash from Financing -11.56
Net change in Cash 38.01
Free Cash Flow 7.17
Particulars MAR 2025 (Values in Cr)
Net Income 0.58
Cash from Operations -1.49
Cash from Investing -27.29
Cash from Financing -79.65
Net change in Cash -105.17
Free Cash Flow -1.49
Particulars MAR 2024 (Values in Cr)
Net Income 51.94
Cash from Operations -2.20
Cash from Investing 119.62
Cash from Financing -10.85
Net change in Cash 101.55
Free Cash Flow 0.09
Particulars MAR 2023 (Values in Cr)
Net Income -7.07
Cash from Operations 5.51
Cash from Investing 0.43
Cash from Financing -12.65
Net change in Cash -6.60
Free Cash Flow 7.39
Particulars MAR 2022 (Values in Cr)
Net Income -8.30
Cash from Operations 7.47
Cash from Investing 8.17
Cash from Financing -10.10
Net change in Cash 4.87
Free Cash Flow 8.88
Particulars MAR 2021 (Values in Cr)
Net Income -11.46
Cash from Operations -12.85
Cash from Investing -27.60
Cash from Financing -7.24
Net change in Cash -36.04
Free Cash Flow -12.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7791.95 71.20 13.65 112036.29 6002.15 / 7981.20
SHREE PACETRONIX LTD. 157.70 54.38 4.11 56.76 61.11 / 221.50
TRANSGENE BIOTEK LTD. 3.93 0.00 2.96 29.78 3.22 / 9.07
VIMTA LABS LIMITED 631.45 46.23 8.19 2810.30 254.43 / 728.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7791.95 82.90 12.82 112036.29 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.00 0.00 -14.62 27.64 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6231.80 30.93 6.27 6817.59 4777.15 / 6525.00

FORTIS MALAR HOSPITALS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
67.42 -0.88 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 68.10
  • 26 Days 69.10
  • 10 Days 68.30
  • 50 Days 70.20
  • 12 Days 68.40
  • 100 Days 70.50
  • 20 Days 68.80
  • 200 Days 68.50
67.84 PIVOT

First Support

67.18

First Resistance

68.68

Second Support

66.34

Second Resistance

69.34

Third Support

65.68

Third Resistance

70.18

RSI

40.59

ADX

12.04

MACD

-0.71

Williams % R

-82.91

Commodity Channel Index (CCI)

-124.25

Date

2025-08-26

Week

11016.00

Same Day

10392.00

Month

9890.00

1 Year

0.72

3 Year

0.37

Over 1 Month

-0.17%

down

Over 1 Year

10.06%

down

Over 3 Months

-11.92%

down

Over 3 Years

5.45%

down

Over 6 Months

15.54%

down

Over 5 Years

6.88%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

FORTIS MALAR HOSPITALS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

FORTIS MALAR HOSPITALS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
24 Jul 2024 2.5 Final 24 Jul 2024 Equity shares
23 Apr 2024 40.0 Interim 23 Apr 2024 Equity shares
14 Sep 2015 0.5 Final 16 Sep 2015 Equity shares
19 Sep 2013 0.5 Interim 20 Sep 2013 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

FORTIS MALAR HOSPITALS LIMITED Share Price

Fortis Malar Hospital Limited, formerly known as Malar Hospital Limited was established on April 12, 1989 to set up, manage and operate a multi-specialty hospital. Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Intermediate Holding Company. Later, the Company changed its name to 'Fortis Malar Hospital Limited' on December 21, 2010. The Hospital building was owned by a fellow subsidiary, Fortis Health Management Limited (FHML) in early 2008.

The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services. With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine

All the above departments are fully became operational under phase I of the project. The second phase of the project envisages enhacement of the number of beds from 100 to 250 beds at an cost of Rs.2120 lacs. To part the project the company came into rights issues during 1995.

The Hospital have started performing Cardio Thoracic surgeries with effect from 13-10-2003. Dr.K M Cherian is leading this cardio Thoracic department. He has won several awards and honors including Padmashree award from the Government. Dr.K M Cherian has conducted around 26,200 cardio thoracic cases including infant heart surgery, heart transplants, paediatric heart transplants and heart and lung transplants. This type of surgery will bring more revenue to the hospital in the comming years. With Dr.K M Cherian at command of cardio thoracic team, the future looks bright.

On 7th September 2007 the Company and the Promoters of the Company entered into a Loan, Share Subscription and Share Purchase Agreement (LSSSPA) with International Hospital Ltd, a wholly owned subsidiary of Fortis Healthcare Limited and Oscar Investments Ltd (Acquirer) for the sale of 39,00,000 Equity Shares by the Promoters of the Company and for availing a loan of Rs 14 crores from
the Acquirers, convertible into Equity Shares of the Company. Further, the Acquirer Companies acquired 39,00,000 Equity Shares from the Promoters of the Companies on 18th February 2008 which together with their existing holding, constituted 62.17% of the Share Capital of the Company. The Management and Control of Affairs of Company is now with the Acquirers, who consequently shall act as Promoters of the Company.

On, 7th July, 2009, Company incorporated a wholly owned subsidiary viz. Malar Stars Medicare Limited.

The Board of Directors of Company on August 19, 2016 approved a Composite Scheme of Arrangement and Amalgamation between Company, Fortis Healthcare Limited (FHL), SRL Limited (SRL) and their respective Shareholders and Creditors for (i) the transfer of the undertaking, business and operations of the Company as a going concern, by way of slump sale, from the Company to FHL, (ii) the transfer by way of a demerger of the undertakings, business, activities and operations of FHL, pertaining to diagnostics business of FHL (Demerged Undertaking) to Company, and consequent issue of Equity Shares by Company to Shareholders of FHL; (iii) amalgamation of all the undertakings and entire business of SRL with Company and dissolution of SRL without winding up; the consequent issue of equity shares by Company to the Shareholders of SRL and the cancellation of equity shares of SRL held by Company and various other matters consequential or otherwise integrally connected therewith. Further, National Company Law Tribunal, Chandigarh, vide its order dated June 15, 2018 approved the scheme as withdrawn and accordingly, as on date, the Scheme was terminated by Company, SRL and FHL.

Pursuant to execution of Share Subscription Agreement on July 13, 2018 (SSA), Northern TK Venture Pte Ltd (NTK or the Acquirer), a wholly owned subsidiary of IHH Berhard, subscribed to 235,294,117 new equity shares of Fortis Healthcare Limited (FHL) with a face value of Rs 10 each, constituting approximately 31.1% of the total voting equity share capital of FHL on a fully diluted basis for a total consideration of Rs 4,000 crore and FHL issued and allotted the Subscription Shares by way of preferential allotment in accordance with the terms of the SSA. As a consequence of Subscription, the Acquirer together with IHH Healthcare Berhad (PAC 1) and Parkway Pantai Limited (PAC 2), made a mandatory Open Offer, by filing a Public Announcement dated July 13, 2018. The Subscription completed in accordance with the terms of the SSA on November 13, 2018 and NTK became the controlling shareholder of FHL.

In 2024-25, Company had sold its business operations pertaining to Malar Hospital, as a going concern via slump sale on February 01, 2024. Post this sale, Company ceased to have any business operations in 2024.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Fortis Malar Hospitals Ltd?

Answer Field

Fortis Malar Hospitals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 67.42 as on Aug 28 2025 03:30 PM.

What is the Market Cap of Fortis Malar Hospitals Ltd Share?

Answer Field

The market cap of Fortis Malar Hospitals Ltd for NSE ₹ 0.00 & for BSE ₹ 126.40 as on Aug 28 2025 03:30 PM.

What is the 52 Week High and Low of Fortis Malar Hospitals Ltd?

Answer Field

The 52 Week High and Low of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 98.70 and ₹ 51.01.

What is 1 year return for Fortis Malar Hospitals Ltd?

Answer Field

The 1 year returns on the stock has been 10.06%.

What is the P/E Ratio of Fortis Malar Hospitals Ltd Share?

Answer Field

As on Aug 28 2025 03:30 PM the price-to-earnings (PE) ratio for Fortis Malar Hospitals Ltd share is 27.43.

What is the PB ratio of Fortis Malar Hospitals Ltd Share?

Answer Field

As on Aug 28 2025 03:30 PM, the price-to-book (PB) ratio for Fortis Malar Hospitals Ltd share is 15.97.

How to Buy Fortis Malar Hospitals Ltd Share?

Answer Field

You can trade in Fortis Malar Hospitals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fortis Malar Hospitals Ltd Share on Bajaj Broking App?

Answer Field

To buy Fortis Malar Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fortis Malar Hospitals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91